针对慢性炎症相关癌症的炎症和免疫调节
Lawan Rabiu1, Mengzhu Chinn1, Feng Chen1
1Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen, China.
Cancer science
|March 10, 2026
概括
慢性炎症导致癌症,特别是结肠炎相关癌症 (CAC) 和肝癌 (MAFLD-HCC). 免疫调节受损,就像减少TIPE2活性一样,促进瘤生长,为预防和治疗提供了目标.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 炎症研究 炎症研究
背景情况:
- 慢性炎症是癌症发展的关键驱动因素,促进基因组不稳定性和恶性转变.
- 与炎症相关的恶性瘤,如结肠炎相关的癌症 (CAC) 和与代谢功能障碍相关的脂肪肝疾病相关的肝细胞癌 (MAFLD-HCC) 产生于长期的前新生阶段.
- 这些癌症具有共同的炎症和瘤性途径,包括IL-6/STAT3和NF-κB信号传递.
研究的目的:
- 在CAC和MAFLD-HCC中合成共享的炎症,免疫和微环境机制.
- 强调免疫调节受损如何促进癌症的发展.
- 突出针对炎症驱动路径的治疗和预防策略.
主要方法:
- 对有关炎症相关癌症的现有文献的综述.
- 对共享的分子和细胞机制的分析.
- 识别免疫调节通路,包括TIPE2.2.
- 综合治疗和预防策略.
主要成果:
- CAC和MAFLD-HCC共享融合机制,涉及持续的炎症信号和遗传变化.
- 内生免疫调节系统的失效,例如TIPE2活性降低,促进了促进瘤的微环境.
- 免疫调节受损对于慢性炎症转化为癌症至关重要.
结论:
- 了解共同的炎症途径对于癌症的预防和治疗都至关重要.
- 针对免疫调节为预防慢性炎症疾病中的癌症和治疗已确定的恶性瘤提供了双重好处.
- 调节由炎症驱动的通路是一个有前途的治疗途径.
相关概念视频
Inflammatory Response
17.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
17.9K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
688
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
688
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
629
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
629


